欢迎您！东篱公司
退出
-
申报数据库
-
立项数据库
-
成果数据库
-
项目获奖数据库
同期刊论文项目
同项目期刊论文
Identification of novel anaplastic lymphoma kinase (ALK) inhibitors using a common feature pharmacop
Structural optimization and structure-activity relationships of N2-(4-(4-Methylpiperazin-1-yl)phenyl
Design, Synthesis, and Structure-Activity Relationship Studies of 3-(Phenylethynyl)-1H-pyrazolo[3,4-
A combined molecular docking-based and pharmacophore-based target prediction strategy with a probabi
Structure-Activity Relationship Studies of Pyrazolo[3,4-d]Pyrimidine Derivatives Leading to the Disc
Discovery of the novel potent and selective FLT3 inhibitor 1-{5-[7-(3- morpholinopropoxy)quinazolin-
SKLB1028, a novel oral multikinase inhibitor of EGFR, FLT3 and Abl, displays exceptional activity in
Accumulation of FLT3+ CD11c+ dendritic cells in psoriatic lesions and the anti-psoriatic effect of a
Structural modification of an EGFR inhibitor that showed weak off-target activity against RET leadin
Discovery and structure–activity analysis of 4-((5-nitropyrimidin-4-yl)amino)benzimidamide derivativ
SC-535, a novel oral multikinase inhibitor, showed potent antitumor activity in human melanoma model
SKLB1206, a novel orally available multikinase inhibitor targeting EGFR activating and T790M mutants
位置：